Parellada Rodón, Eduard
Eduard Parellada
VIAF ID: 87210036 (Personal)
Permalink: http://viaf.org/viaf/87210036
Preferred Forms
- 100 0 _ ‡a Eduard Parellada
- 100 1 0 ‡a Parellada Rodón, Eduard
-
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia. | |
Actividad cerebral medida con SPECT de perfusión en la esquizofrenia aguda | |
Alucinaciones auditivas en la esquizofrenia : estudio del metabolismo cerebral mediante PET con F18-FDG durante el primer episodio psicótico, tras remisión clínica y tras estimulación auditivo-lingüística | |
Antipsychotic therapy amongst Cytochrome P450 2D6 poor metabolizers in the clinical practice: A case report. | |
Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls. | |
ARVCF single marker and haplotypic association with schizophrenia. | |
Cannabis use and age of diagnosis of schizophrenia | |
Casos clínicos en esquizofrenia 2017 : psicopatología en los nuevos tiempos | |
A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. | |
A continuous emotional task activates the left amygdala in healthy volunteers: (18)FDG PET study | |
CYP2D6*3, *4, *5 AND *6 POLYMORPHISMS AND ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY | |
Delirium y demencia | |
Diferencias en la respuesta a pruebas de reconocimiento facial de las emociones entre pacientes esquizofrénicos deficitarios versus esquizofrénicos no deficitarios | |
Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics. | |
Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint. | |
Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study | |
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies | |
Esquizofrenia : del caos mental a la esperanza | |
Estudio de la presinapsis dopaminérgica estriatal con [123I] FP-CIT en pacientes con esquizofrenia y parkinsonismo | |
Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation. | |
Glucose abnormalities in the siblings of people with schizophrenia | |
¿Hikikomori o esquizofrenia simple? | |
Hypophyseal response to ECT: a higher and faster vasopressin peak. | |
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population | |
Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics | |
Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes | |
Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes | |
Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study | |
Manic syndrome associated with efavirenz overdose | |
Metabolic syndrome or glucose challenge in first episode of psychosis? | |
Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients. | |
Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms. | |
Neural bases of auditory hallucinations in schizophrenia | |
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells | |
An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study). | |
Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients. | |
Plasma levels of oral risperidone during enteral nutrition in a pregnant schizophrenic patient. | |
Polimorfismos genéticos en la catecol-O-metiltransferasa y riesgo de esquizofrenia en población española | |
[Probable levetiracetam-induced psychosis] | |
Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a review | |
Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM. | |
Psychiatric self-assessment & review | |
Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies. | |
Regional cerebral blood flow pattern in normal young and aged volunteers: a 99mTc-HMPAO SPET study. | |
The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients. | |
Risperdal CONSTA la experiencia clínica | |
Role of the cingulate gyrus during the Wisconsin Card Sorting Test: a single photon emission computed tomography study in normal volunteers. | |
Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disorders. | |
Screening for substance use disorders in first-episode psychosis: implications for readmission | |
Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients. | |
[Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone] | |
Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis | |
Transportador de la dopamina (DAT) y pronóstico de la esquizofrenia : estudio prospectivo de una cohorte evaluado mediante datscan, RM volumétrica y el polimorfismo -67 A/T del gen del dat | |
Trastorno límite de la personalidad | |
Trastornos de ansiedad : autoevaluación y actualización en psiquiatría | |
Trastornos por abuso de sustancias | |
Treatment of narcolepsy complicated by psychotic symptoms |